C3i obtained a Drug Establishment License (DEL) to produce cell therapies for patients across Canada commercially.
C3i became the first contract development and manufacturing organization (CDMO) for cell and gene therapies in Canada to obtain a Drug Establishment License (DEL) to produce life-saving cell therapies ...